Navigation Links
New Drug May Help Patients With Irregular Heartbeat Avoid Stroke
Date:2/11/2011

rillation by about 20 percent, according to background information in the study.

In the new study of apixaban, researchers assigned almost 5,600 patients with atrial fibrillation and an increased risk of stroke (due to age or prior stroke, for instance) to one of two groups: apixaban, at 5 milligrams taken twice daily; or aspirin, with doses ranging from 81 to 324 milligrams per day.

The study was done at 522 centers in 36 countries from late 2007 to late 2009. The researchers wanted to compare which drug was better at preventing stroke or blockages due to blood clots elsewhere in the body, called systemic embolism.

Among patients on apixaban, there were 51 strokes or embolisms, or 1.6 percent per year, compared to 113 such events, or 3.7 percent, among those on aspirin.

While apixaban patients experienced 44 major bleeding events, aspirin takers had 39, but the difference was not great enough to be significant from a statistical point of view, Diener said.

The study was funded by Bristol-Myers Squibb and Pfizer, who are working jointly to develop apixaban.

The drug has been shown in previous research to be better at preventing dangerous leg blood clots and lung clots after hip replacement surgery than an older drug, enoxaparin.

Apixaban works by blocking a crucial step in the formation of blood clots. The study of the drug's effects on stroke prevention was actually halted early after one year, Diener said, because of the huge difference found between the two drugs and the superiority of apixaban.

The new drug isn't yet approved by the FDA and Diener couldn't predict when that might happen. Results of another study, a head-to-head comparison of apixaban against warfarin, is due out in August, he said.

A 55 percent reduction in stroke risk compared to aspirin is impressive, said Dr. Larry Chinitz, professor of medicine at the New York University School of Medicine and director of the Heart Rhythm Center at NYU
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Few Stroke Patients Given Clot-Buster Quickly Enough: Study
2. Non-dopaminergic drug preladenant reduces motor fluctuations in patients with Parkinsons disease
3. Everolimus improves progression-free survival for patients with rare pancreatic cancer
4. Researchers: Elderly patients 4 times more likely to die from treatment complications
5. Using pharmacist-directed service improves quality of care for patients
6. Improving care for bowel cancer patients
7. Early infusion of donor T cells prevents graft versus host disease in blood cancer patients
8. Researchers Craft Blood Vessels for Heart, Kidney Patients
9. Prehabilitation better prepares patients for knee replacement surgery
10. For-Profit Hospices May Prefer Certain Types of Patients: Study
11. Will Loss of Lethal Injection Drug Harm Surgical Patients?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Drug May Help Patients With Irregular Heartbeat Avoid Stroke
(Date:3/4/2015)... (PRWEB) March 04, 2015 RapidScale, a ... in Las Vegas, Nevada, on March 16th-18th. They are ... will have some of its top engineering executives in ... in the RapidScale solution set. Attendees include William Hiatt, ... Cloud Engineer; and Ryan Turpin, Cloud Support Manager. ...
(Date:3/4/2015)... SIGVARIS proved innovative when they ... compression therapy collection designed exclusively for men. Building ... is proud to announce the launch of three additional ... from a unique, extremely fine synthetic fiber, MIDTOWN MICROFIBER ... and thigh-highs offer a tailored look that is perfect ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The ... discussion leaders for its upcoming fifth annual Advanced ... Paris, France. The event this year will feature ... than 20 of the field’s leading companies and ... together top executives and clinical researchers from the ...
(Date:3/4/2015)... Jeannie Mai, TV personality, fashion maven, and co-host of ... the print publication. Mai embraces the overall theme of the ... clothes and personal care products. In an exclusive interview, Olympic ... an organic diet. She mentions, “Having an organic lifestyle has ... also now as I’m a full time student at New ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 i2i ... been selected by Chase Brexton Health Care, a ... today. , Chase Brexton provides comprehensive primary care, ... 30,000 patients across seven clinics in the greater ... of electronic medical records, the organization has always ...
Breaking Medicine News(10 mins):Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 2Health News:Rapidscale to Host First Cloudtalk Events at Channel Partners in Las Vegas 3Health News:Building on the Success of MIDTOWN MICROFIBER, SIGVARIS Expands Popular Compression Collection with Longer Foot Length Offerings 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 2Health News:The Alliance for Regenerative Medicine Announces Agenda for Upcoming Advanced Therapies Summit 3Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 2Health News:Chase Brexton Selects i2i Systems Population Health Management Solutions to Demonstrate HEDIS Quality Outcomes to Maryland’s Health Plans 3
... eating dietary fiber specifically from fruits and cereals lowers ... // a connection between higher intake of fiber and ... actually looked at the dietary fiber from different sources ... study researchers analyzed several studies to determine whether the ...
... , medication errors that occur in pediatric intensive care units ... ,Researchers studied more than 11,800 children who were admitted into ... errors. They defined an error as any preventable event that ... medical errors were reported during the course of the study. ...
... A new study shows weight gain after age 18 can ... women who // are not taking hormone replacement therapy. ... to 74, by asking them about their weight at age ... been periodically asked to provide updates on their weight, in ...
... lose significant bone mass in the first year after the ... their bodies from rejecting the new organ. The bone loss ... of fractures among this group ranges from 22 percent to ... treatment, but which drugs work best in this situation is ...
... a recent study conducted researchers suggest that kids who ... having their tonsils and adenoids out. ,Adenotonsillectomy is ... of the time, it is performed to treat recurring ... have also used the surgery to treat obstructive sleep ...
... strikes men between 20 and 34 years old. Advances ... improved survival rate from the cancer, but since men ... the effect of the cancer and its treatment on ... treatment reduces fertility, others have found fertility rates unchanged. ...
Cached Medicine News:
(Date:3/4/2015)...  Kannalife Sciences, Inc. ("Kannalife") announces that Dr. ... Board to assist the Company in the advancement of ... cannabinoid therapeutics for the treatment of Chronic Traumatic Encephalopathy ... conducting the full autopsy of Mike Webster , ... Pittsburgh Steelers. It was through his examination of ...
(Date:3/4/2015)... Ga., March 4, 2015  Halyard Health, Inc. (NYSE: ... and provided its 2015 outlook and related key planning ... Halyard Health as we report our fourth quarter results, ... Chairman and CEO. "We executed a smooth separation from ... the spin-off. We delivered sales growth and margin improvement ...
(Date:3/4/2015)... , March 4, 2015  ECR Booth #317/Expo ... ) is showcasing a full spectrum of X-ray imaging ... quality, reduce costs, and enable greater patient throughput for ... imaging systems.  These solutions are on display at the ... Vienna, Austria this week.   ...
Breaking Medicine Technology:Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 2Kannalife Sciences, Inc. Announces the Addition of Dr. Bennet Omalu, Renowned Pathologist and Founder of Chronic Traumatic Encephalopathy, to its Scientific Advisory Board 3Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 2Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 3Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 4Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 5Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 6Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 7Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 8Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 9Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 10Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 11Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 12Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 13Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 14Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 15Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 16Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 17Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 18Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 19Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 20Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 21Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 22Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 23Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 24Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 25Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 26Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 27Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 28Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 29Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 30Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 31Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 2Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 3
... 2011 Argos Therapeutics, Inc. today announced that its late ... awarded the Nobel Prize in medicine for the discovery of ... Dr. Steinman,s discovery of dendritic cells and his research ... in adaptive immunity have led to the development of Argos, ...
... Today, Children,s Hospital at Scott & White , the ... facility between Dallas and Austin, opened its doors to patients. ... state-of-the-art Simulation Center for a mock transport of "patients" from ... White Hospital-Temple, before moving patients to the new Children,s Hospital ...
Cached Medicine Technology:Argos Therapeutics' Late Scientific Co-founder Ralph Steinman, M.D., Awarded Nobel Prize in Medicine for Discovery of Dendritic Cells as Critical Sentinels of Immune System 2Children's Hospital at Scott & White Opens 2Children's Hospital at Scott & White Opens 3Children's Hospital at Scott & White Opens 4
...
Pre-set guard for precise depth incision, bi-directional blade can cut left or right. 250 micron....
...
Tips are sharp on both sides to puncture, cut and tear the capsule...
Medicine Products: